合成路线1
该中间体在本合成路线中的序号:
(IX) A new synthesis for edatrexate has been described:
The reaction of 2,4-diamino-6-(bromomethyl)pteridine (I) with tributylphosphine (II) in DMSO gives the corresponding phosphonium salt (III), which is condensed wtih 4-propionylbenzoic acid methyl ester (IV) by means of NaH in DMSO, affording 4-[1-(2,4-diaminopteridin-6-yl)-1-ethylvinyl]benzoic acid methyl ester (V). The hydrogenation of (V) with H2 and PtO2 in acetic acid gives 4-[1-(2,4-diamino-6,7-dihydropteridin-6-ylmethyl)propyl]benzoic acid methyl ester (VI), which, without isolation, is dehydrogenated with H2O2 in the same solvent yielding 4-[1-(2,4-diaminopteridin-6-ylmethyl)propyl]benzoic acid methyl ester (VII). The hydrolysis of (VII) with NaOH in DMSO - water affords the corresponding free acid (VIII), which is condensed with L-glutamic acid diethyl ester (IX) by means of isobutoxycarbonylchloride and triethylamine in DMF, giving edatrexate diethyl ester (X). Finally, this compound is hydrolyzed with NaOH in methanol.
【1】
Johnson, C.A.; Sirotnak, F.M.; Piper, J.R.; Otter, G.M.; Synthesis and antifolate evaluation of 10-ethyl-5-methyl-5,10-dideazaaminopterin and an alternative synthesis of 10-ethyl-10-deazaaminopterin (edatrexate). J Med Chem 1992, 35, 16, 3002.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11006 |
2-Amino-6-(bromomethyl)-4-pteridinylamine; 6-(Bromomethyl)-2,4-pteridinediamine
|
52853-40-4 |
C7H7BrN6 |
详情 | 详情
|
(III) |
11007 |
Tributyl[(2,4-diamino-6-pteridinyl)methyl]phosphonium bromide
|
|
C19H34BrN6P |
详情 |
详情
|
(IV) |
11008 |
methyl 4-propionylbenzoate
|
|
C11H12O3 |
详情 |
详情
|
(V) |
11009 |
methyl 4-[(E)-2-(2,4-diamino-6-pteridinyl)-1-ethylethenyl]benzoate
|
|
C18H18N6O2 |
详情 |
详情
|
(VI) |
11010 |
methyl 4-[1-[(2,4-diamino-5,6,7,8-tetrahydro-6-pteridinyl)methyl]propyl]benzoate
|
|
C18H24N6O2 |
详情 |
详情
|
(VII) |
11011 |
methyl 4-[1-[(2,4-diamino-6-pteridinyl)methyl]propyl]benzoate
|
|
C18H20N6O2 |
详情 |
详情
|
(VIII) |
11012 |
4-[1-[(2,4-Diamino-6-pteridinyl)methyl]propyl]benzoic acid
|
|
C17H18N6O2 |
详情 |
详情
|
(IX) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(X) |
11014 |
diethyl (2S)-2-[(4-[1-[(2,4-diamino-6-pteridinyl)methyl]propyl]benzoyl)amino]pentanedioate
|
|
C26H33N7O5 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(I) The acylation of diethyl L-glutamate (I) with 5-nitro-2-thienylcarbonyl chloride (II) in toluene gives N-(5-nitrothien-2-ylcarbonyl)-L-glutamic acid diethyl ester (III), which is reduced with sodium dithionite in ethanol/water to the corresponding amino compound (IV). The methylation of (IV) with methyl iodide and 2,6-lutidine yields the corresponding methylamine (V), which is condensed with 6-(bromomethyl)-2-methylquinazolin-4(3H)-one (VI) by means of 2,6-lutidine in hot DMF affording the diethyl ester (VIII) of D-1694. Finally, this compound is hydrolyzed with NaOH in ethanol/water.
The bromomethyl quinazoline (VI) was obtained by selective radical bromination of 2,6-dimethylquinazolin-4(3H)-one (VII) with N-bromosuccinimide (NBS) and benzoyl peroxide in hot chloroform.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(II) |
12467 |
5-Nitro-2-thiophenecarbonyl chloride
|
|
C5H2ClNO3S |
详情 |
详情
|
(III) |
12468 |
diethyl (2S)-2-[[(5-nitro-2-thienyl)carbonyl]amino]pentanedioate
|
|
C14H18N2O7S |
详情 |
详情
|
(IV) |
12469 |
diethyl (2S)-2-[[(5-amino-2-thienyl)carbonyl]amino]pentanedioate
|
|
C14H20N2O5S |
详情 |
详情
|
(V) |
12470 |
diethyl (2S)-2-([[5-(methylamino)-2-thienyl]carbonyl]amino)pentanedioate
|
112889-02-8 |
C15H22N2O5S |
详情 | 详情
|
(VI) |
12471 |
6-(Bromomethyl)-2-methyl-4(3H)-quinazolinone
|
|
C10H9BrN2O |
详情 |
详情
|
(VII) |
12472 |
2,6-Dimethyl-4(3H)-quinazolinone
|
|
C10H10N2O |
详情 |
详情
|
(VIII) |
12473 |
diethyl (2S)-2-[[(5-[methyl[(2-methyl-4-oxo-3,4-dihydro-6-quinazolinyl)methyl]amino]-2-thienyl)carbonyl]amino]pentanedioate
|
|
C25H30N4O6S |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(XX) The reduction of 4-bromophenylacetic acid (I) with boron hydride gives 2-(4-bromophenyl)ethanol (II), which is mesylated with methanesulfonyl chloride to the sulfonate (III). The condensation of (III) with diethyl malonate (IV) by means of NaH yields 2-[2-(4-bromophenyl)ethyl]malonic acid diethyl ester (V), which is reduced with LiAlH4 to the diol (VI). The enantioselective transesterification of (VI) with methyl acetate by means of porcine pancreatic lipase (PPL, Sigma type II, no. 3126) affords the (R)-enantiomer of monoester (VII), which is treated with tert-butyldimethylsilyl chloride in dichloromethane, giving the (S)-enantiomer of the silylated acetoxy derivative (VIII). The hydrolysis of (VIII) with methanolic NaOH yields the silylated alcohol (IX), which is mesylated with methanesulfonyl chloride as before affording the sulfonate (X). The reaction of (X) with sodium azide in hot DMF gives 1-azido-4-(4-bromophenyl)-2(S)-(tert-butyldimethylsilyloxymethyl)butane (XIII), which is deprotected with acetic acid in THF yielding 2(S)-(azidomethyl)-4-(4-bromophenyl)butanol (XII). Mesylation of (XII) as before affords sulfonate (XIII), which is condensed with diethyl malonate (IV) by means of NaH as before, giving the chiral malonate derivative (XIV). The cyclization of (XIV) by means of tributyl phosphine in THF yields (3RS,5R)-5-[2-(4-bromophenyl)ethyl]-2-oxopiperidine-3-carboxylic acid ethyl ester (XV), which is treated with trimethyloxonium tetrafluoroborate in CHCl3 to afford the methoxy derivative (XVI). Cyclization of (XVI) with guanidine hydrochloride (XXII) by means of sodium ethoxide in hot ethanol gives 2-amino-6(R)-[2-(4-bromophenyl)ethyl]-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine (XVII), which is treated with copper cyanide in refluxing 1-methyl-2-pyrrolidone, yielding the nitrile (XVIII). Hydrolysis of (XVIII) with refluxing 6N HCl affords the corresponding benzoic acid (XIX), which is condensed with L-glutamic acid diethyl ester (XX) by means of N-methylmorpholine and 2-chloro-4,6-dimethoxy-1,3,5-triazine in DMF, affording the diethyl ester of the desired product (XXI). Finally, this compound is hydrolyzed with 1N NaOH.
【1】
Barnett, C.J.; Wilson, T.M. (Eli Lilly and Company); Enantioselective synthesis of antifolates. EP 0417212 .
|
【2】
Barnett, C.J.; Wilson, T.M.; Asymmetric synthesis and absolute configuration of 5,10-dideaza-5,6,7,8-tetrahydropteroic acid and 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF). Tetrahedron Lett 1989, 30, 46, 6291.
|
【3】
Castaner, J.; Prous, J.; Lometrexol. Drugs Fut 1993, 18, 2, 121.
|
【4】
Wilson, T.M.; Barnett, C.J.; Asymmetric synthesis and absolute configuration of 5,10-dideaza-5,6,7,8-tetrahydropteroic acid and 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF). Chemistry and Biology of Pteridines (1989): Pteridines and Folic Acid Derivatives. H.-C. Curtius, S. Ghisla and N. Blau (Eds.). de Gruyter, New York 1990, 102. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14247 |
2-(4-Bromophenyl)acetic acid; p-Bromophenylacetic acid; 4-Bromophenylacetic acid
|
1878-68-8 |
C8H7BrO2 |
详情 | 详情
|
(II) |
14248 |
2-(4-Bromophenyl)-1-ethanol; 4-Bromophenethyl alcohol;2-(4-bromophenyl)ethanol;2-(4-Bromophenyl)ethan-1-ol |
4654-39-1 |
C8H9BrO |
详情 | 详情
|
(III) |
14249 |
4-Bromophenethyl methanesulfonate
|
|
C9H11BrO3S |
详情 |
详情
|
(IV) |
16829 |
Diethyl malonate
|
105-53-3 |
C7H12O4 |
详情 | 详情
|
(V) |
14251 |
diethyl 2-(4-bromophenethyl)malonate
|
|
C15H19BrO4 |
详情 |
详情
|
(VI) |
14252 |
2-(4-Bromophenethyl)-1,3-propanediol
|
|
C11H15BrO2 |
详情 |
详情
|
(VII) |
14253 |
(2R)-4-(4-bromophenyl)-2-(hydroxymethyl)butyl acetate
|
|
C13H17BrO3 |
详情 |
详情
|
(VIII) |
14254 |
(2S)-4-(4-bromophenyl)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)butyl acetate
|
|
C19H31BrO3Si |
详情 |
详情
|
(IX) |
14255 |
(2S)-4-(4-Bromophenyl)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)-1-butanol
|
|
C17H29BrO2Si |
详情 |
详情
|
(X) |
14256 |
(2R)-4-(4-bromophenyl)-2-([[tert-butyl(dimethyl)silyl]oxy]methyl)butyl methanesulfonate
|
|
C18H31BrO4SSi |
详情 |
详情
|
(XI) |
14257 |
[[(2S)-2-(Azidomethyl)-4-(4-bromophenyl)butyl]oxy](tert-butyl)dimethylsilane; (2S)-2-(Azidomethyl)-4-(4-bromophenyl)butyl tert-butyl(dimethyl)silyl ether
|
|
C17H28BrN3OSi |
详情 |
详情
|
(XII) |
14258 |
(2S)-2-(Azidomethyl)-4-(4-bromophenyl)-1-butanol
|
|
C11H14BrN3O |
详情 |
详情
|
(XIII) |
14259 |
(2S)-2-(azidomethyl)-4-(4-bromophenyl)butyl methanesulfonate
|
|
C12H16BrN3O3S |
详情 |
详情
|
(XIV) |
14260 |
diethyl 2-[(2R)-2-(azidomethyl)-4-(4-bromophenyl)butyl]malonate
|
|
C18H24BrN3O4 |
详情 |
详情
|
(XV) |
14261 |
ethyl (5R)-5-(4-bromophenethyl)-2-oxohexahydro-3-pyridinecarboxylate
|
|
C16H20BrNO3 |
详情 |
详情
|
(XVI) |
14268 |
ethyl (5R)-5-(4-bromophenethyl)-2-methoxy-3,4,5,6-tetrahydro-3-pyridinecarboxylate
|
|
C17H22BrNO3 |
详情 |
详情
|
(XVII) |
14263 |
(6R)-2-Amino-6-(4-bromophenethyl)-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-4(3H)-one
|
|
C15H17BrN4O |
详情 |
详情
|
(XVIII) |
14264 |
4-[2-[(6R)-2-Amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzonitrile
|
|
C16H17N5O |
详情 |
详情
|
(XIX) |
14265 |
4-[2-[(6R)-2-Amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoic acid
|
|
C16H18N4O3 |
详情 |
详情
|
(XX) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(XXI) |
14267 |
diethyl (2S)-2-[(4-[2-[(6R)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl)amino]pentanedioate
|
|
C25H33N5O6 |
详情 |
详情
|
(XXII) |
14262 |
Guanidine hydrochloride
|
50-01-1 |
CH5N3.HCl |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(VI*) Racemic lometrexol has been prepared.
【1】
Okazaki, S.; Asao, T.; Wakida, M.; Ishida, K.; Washinosu, M.; Utsugi, T.; Yamada, Y. (Taiho Pharmaceutical Co., Ltd.); Novel fused indan deriv. and pharmaceutically acceptable salt. EP 0713870; US 5710162; US 5733918; WO 9532187 .
|
【2】
Castaner, J.; Prous, J.; Lometrexol. Drugs Fut 1993, 18, 2, 121.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI*) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(I) |
14269 |
2,4-Diaminopyrido[2,3-d]pyrimidine-6-carbonitrile
|
|
C8H6N6 |
详情 |
详情
|
(II) |
14270 |
2,4-Diaminopyrido[2,3-d]pyrimidine-6-carbaldehyde
|
|
C8H7N5O |
详情 |
详情
|
(III) |
14271 |
[4-(Methoxycarbonyl)benzyl](diphenyl)phosphonium
|
|
C21H20O2P |
详情 |
详情
|
(IV) |
14272 |
methyl 4-[(E)-2-(2,4-diaminopyrido[2,3-d]pyrimidin-6-yl)ethenyl]benzoate
|
|
C17H15N5O2 |
详情 |
详情
|
(V) |
14273 |
4-[(E)-2-(2-Amino-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl)ethenyl]benzoic acid
|
|
C16H12N4O3 |
详情 |
详情
|
(VII) |
14275 |
diethyl (2S)-2-([4-[(E)-2-(2-amino-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl)ethenyl]benzoyl]amino)pentanedioate
|
|
C25H27N5O6 |
详情 |
详情
|
(VIII) |
14276 |
diethyl (2S)-2-([4-[2-(2-amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl)ethyl]benzoyl]amino)pentanedioate
|
|
C25H33N5O6 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(XIV) Racemic lometrexol has been prepared.
【1】
Harrington, P.M.; Shih, C.; Grindey, G.B.; Gossett, L.S.; Moran, R.G.; Taylor, S.C.; Synthesis and structure-activity relationship studies of 5,10-dideazatetrahydrofolic acid (DDATHF). Chemistry and Biology of Pteridines (1989): Pteridines and Folic Acid Derivatives. H.-C. Curtius, S. Ghisla and N. Blau (Eds.). de Gruyter, New York 1990, 1035. |
【2】
Taylor, E.C.; Wong, G.S.K.; Convergent and efficient palladium-effected synthesis of 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF). J Org Chem 1989, 54, 15, 3618.
|
【3】
Castaner, J.; Prous, J.; Lometrexol. Drugs Fut 1993, 18, 2, 121.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
51602 |
1-Propyne
|
|
C3H4 |
详情 |
详情
|
(I) |
14277 |
2,6-Diamino-4(3H)-pyrimidinone
|
|
C4H6N4O |
详情 |
详情
|
(II) |
14278 |
2-Bromomalonaldehyde
|
|
C3H3BrO2 |
详情 |
详情
|
(III) |
14279 |
2-Amino-6-bromopyrido[2,3-d]pyrimidin-4(3H)-one
|
|
C7H5BrN4O |
详情 |
详情
|
(IV) |
14280 |
N-(6-Bromo-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)-2,2-dimethylpropanamide
|
|
C12H13BrN4O2 |
详情 |
详情
|
(V) |
14281 |
2,2-Dimethyl-N-[4-oxo-6-[2-(trimethylsilyl)ethynyl]-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl]propanamide
|
|
C17H22N4O2Si |
详情 |
详情
|
(VI) |
14282 |
N-(6-Ethynyl-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)-2,2-dimethylpropanamide
|
|
C14H14N4O2 |
详情 |
详情
|
(VII) |
14283 |
diethyl (2S)-2-[(4-iodobenzoyl)amino]pentanedioate
|
|
C16H20INO5 |
详情 |
详情
|
(VIII) |
14284 |
diethyl (2S)-2-[[4-(2-[2-[(2,2-dimethylpropanoyl)amino]-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl]ethynyl)benzoyl]amino]pentanedioate
|
|
C30H33N5O7 |
详情 |
详情
|
(IX) |
14285 |
tert-butyl 4-ethynylbenzoate
|
|
C13H14O2 |
详情 |
详情
|
(X) |
14286 |
tert-butyl 4-bromobenzoate
|
|
C11H13BrO2 |
详情 |
详情
|
(XI) |
14287 |
diethyl (2S)-2-[(4-ethynylbenzoyl)amino]pentanedioate
|
|
C18H21NO5 |
详情 |
详情
|
(XII) |
14288 |
tert-butyl 4-(2-[2-[(2,2-dimethylpropanoyl)amino]-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl]ethynyl)benzoate
|
|
C25H26N4O4 |
详情 |
详情
|
(XIII) |
14289 |
4-(2-[2-[(2,2-Dimethylpropanoyl)amino]-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl]ethynyl)benzoic acid
|
|
C21H18N4O4 |
详情 |
详情
|
(XIV) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(XV) |
14291 |
diethyl (2S)-2-[[4-(2-[2-[(2,2-dimethylpropanoyl)amino]-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl)benzoyl]amino]pentanedioate
|
|
C30H41N5O7 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(XIII) Racemic lometrexol has been prepared.
【1】
Taylor, E.C.; Beardsley, G.P.; Harrington, P.J.; Fletcher, S.R. (Princeton University); Pyrido[2,3-d]pyrimidin derivs. AU 8655108; EP 0215063; ES 8704167; ES 8801268; JP 1996193084; WO 8605181 .
|
【2】
Beardsley, G.P.; Taylor, E.C.; Shih, C.J.; Wong, G.S.K.; Fletcher, S.R.; Harrington, P.J.; Synthesis of 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF) and analogs. Chemistry and Biology of Pteridines (1986): Pteridines and Folic Acid Derivatives. B.A. Cooper and V.M. Whitehead (Eds.). de Gruyter, Berlin 1986, 61. |
【3】
Castaner, J.; Prous, J.; Lometrexol. Drugs Fut 1993, 18, 2, 121.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
14790 |
Guanidine
|
113-00-8 |
CH5N3 |
详情 | 详情
|
(I) |
14299 |
5-Methyl-2-thioxo-2,3-dihydro-3-pyridinecarbonitrile
|
|
C7H6N2S |
详情 |
详情
|
(II) |
14300 |
5-Methyl-2-[(4-nitrophenyl)sulfanyl]nicotinonitrile
|
|
C13H9N3O2S |
详情 |
详情
|
(III) |
14301 |
5-(Bromomethyl)-2-[(4-nitrophenyl)sulfanyl]nicotinonitrile
|
|
C13H8BrN3O2S |
详情 |
详情
|
(IV) |
14302 |
([6-[(4-Nitrophenyl)sulfanyl]-3-pyridinyl]methyl)(triphenyl)phosphonium bromide
|
|
C30H24BrN2O2PS |
详情 |
详情
|
(V) |
14303 |
tert-butyl 4-formylbenzoate
|
|
C12H14O3 |
详情 |
详情
|
(VI) |
14304 |
tert-butyl 4-((E)-2-[5-cyano-6-[(4-nitrophenyl)sulfanyl]-3-pyridinyl]ethenyl)benzoate
|
|
C25H21N3O4S |
详情 |
详情
|
(VII) |
14305 |
tert-butyl 4-[(E)-2-(6-amino-5-cyano-3-pyridinyl)ethenyl]benzoate
|
|
C19H19N3O2 |
详情 |
详情
|
(VIII) |
14306 |
tert-butyl 4-[(E)-2-(2,4-diaminopyrido[2,3-d]pyrimidin-6-yl)ethenyl]benzoate
|
|
C20H21N5O2 |
详情 |
详情
|
(IX) |
14307 |
4-[(E)-2-(2,4-diaminopyrido[2,3-d]pyrimidin-6-yl)ethenyl]benzoic acid
|
|
C16H13N5O2 |
详情 |
详情
|
(X) |
14273 |
4-[(E)-2-(2-Amino-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl)ethenyl]benzoic acid
|
|
C16H12N4O3 |
详情 |
详情
|
(XI) |
14309 |
acetic 4-[(E)-2-[2-(acetamido)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl]ethenyl]-1-benzenecarboxylic anhydride
|
|
C20H16N4O5 |
详情 |
详情
|
(XII) |
14310 |
4-[(E)-2-[2-(acetamido)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl]ethenyl]benzoic acid
|
|
C18H14N4O4 |
详情 |
详情
|
(XIII) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(XIV) |
14311 |
diethyl (2S)-2-[(4-[(E)-2-[2-(acetamido)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl]ethenyl]benzoyl)amino]pentanedioate
|
|
C27H29N5O7 |
详情 |
详情
|
(XV) |
14312 |
diethyl (2S)-2-[(4-[2-[2-(acetamido)-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl)amino]pentanedioate
|
|
C27H35N5O7 |
详情 |
详情
|
(XVI) |
14313 |
diethyl (2S)-2-[(4-[2-[(6R)-2-(acetamido)-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl)amino]pentanedioate
|
|
C27H35N5O7 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(XXI) 2) The reaction of 4-(2-formylethyl)benzoic acid ethyl ester (XIV) with paraformaldehyde (XV) by means of N-ethylbenzothiazolium bromide (XVI) and triethylamine gives the 4-hydroxy-3-oxobutyl derivative (XVII), which is condensed with ethyl cyanoacetate (I) by means of triethylamine in ethanol yielding the furancarboxylate derivative (XVIII). The cyclization of (XVIII) with guanidine (IV) by means of sodium ethoxide in ethanol affords 4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl] benzoic acid ethyl ester (XIX), which is saponified with NaOH to the corresponding free acid (XX). The condensation of (XX) with L-glutamic acid diethyl ester (XXI) in the usual way affords the diethyl ester of LY-231514 (XXII), which is finally saponified with NaOH.
【1】
Castaner, J.; Graul, A.; Tracy, M.; Penetrexed Disodium. Drugs Fut 1998, 23, 5, 498.
|
【2】
Taylor, E.C.; Patel, H.H. (Princeton University); Process for the preparation of pyrrolo[2,3-d]pyrimidines. CA 2084490 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11877 |
Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate
|
105-56-6 |
C5H7NO2 |
详情 | 详情
|
(IV) |
14470 |
2-[(4R)-3,4-dihydro-2H-chromen-4-yl]-N-[(1R)-2-hydroxy-1-phenylethyl]acetamide
|
|
C19H21NO3 |
详情 |
详情
|
(XIV) |
14800 |
ethyl 4-(3-oxopropyl)benzoate
|
|
C12H14O3 |
详情 |
详情
|
(XVI) |
14801 |
3-Ethylbenzothiazolium bromide; 3-Ethyl-1,3-benzothiazol-3-ium bromide
|
32446-47-2 |
C9H10BrNS |
详情 | 详情
|
(XVII) |
14802 |
Ethyl 4-(4-hydroxy-3-oxobutyl)benzoate
|
|
C13H16O4 |
详情 |
详情
|
(XVIII) |
14803 |
Ethyl 2-amino-4-[4-(ethoxycarbonyl)phenethyl]-3-furoate
|
|
C18H21NO5 |
详情 |
详情
|
(XIX) |
14804 |
Ethyl 4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate
|
|
C17H18N4O3 |
详情 |
详情
|
(XX) |
14805 |
4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid
|
|
C15H14N4O3 |
详情 |
详情
|
(XXI) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(XXII) |
14807 |
diethyl (2S)-2-([4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino)pentanedioate
|
|
C24H29N5O6 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(X) A concise and scalable synthesis of pemetrexed disodium has been presented:
The alkylation of methyl 4-bromobenzoate (I) with 3-butyn-1-ol (II) by means of Pd(0) gives methyl 4-(4-hydroxy-1-butynyl)benzoate (III), which is reduced with H2 over Pd/C to the 4-hydroxybutyl derivative (IV). The oxidation of (IV) with NaOCl and 2,2,6,6-tetramethyl-1-piperidinyloxy free radical (TEMPO) yields the corresponding aldehyde (V), which is brominated with 5,5-dibromobarbituric acid (DBBA) and HBr in acetic acid/dichloromethane affording the alpha-bromoaldehyde (VI). The cyclization of (VI) with 2,6-diaminopyrimidin-4(3H)-one (VII) by means of NaOAc in acetonitrile/water gives the pyrrolopyrimidine (VIII), which is hydrolyzed with aqueous NaOH and acidified with aqueous HCl yielding the benzoic acid derivative (IX). The condensation of (IX) with L-glutamic acid diethyl ester (X) by means of 2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) and NMM in DMF affords the diethyl ester (XI) of pemetrexed, which is finally hydrolyzed with aqueous NaOH.
【1】
Kjell, D.P.; Slattery, B.J.; Improved route to multitargeted antifolate LY231514. 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst ORG 130.
|
【2】
Kobierski, M.E.; Wilson, T.M.; Barnett, C.J.; A practical synthesis of multitargeted antifolate LY231514. Org Process Res Dev 1999, 3, 3, 184.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10168 |
4-Bromobenzoic acid methyl ester; methyl 4-bromobenzoate
|
619-42-1 |
C8H7BrO2 |
详情 | 详情
|
(II) |
32507 |
3-butyn-1-ol
|
927-74-2 |
C4H6O |
详情 | 详情
|
(III) |
35243 |
methyl 4-(4-hydroxy-1-butynyl)benzoate
|
|
C12H12O3 |
详情 |
详情
|
(IV) |
35241 |
methyl 4-(4-hydroxybutyl)benzoate
|
|
C12H16O3 |
详情 |
详情
|
(V) |
14808 |
methyl 4-(4-oxobutyl)benzoate
|
|
C12H14O3 |
详情 |
详情
|
(VI) |
35242 |
methyl 4-(3-bromo-4-oxobutyl)benzoate
|
|
C12H13BrO3 |
详情 |
详情
|
(VII) |
14277 |
2,6-Diamino-4(3H)-pyrimidinone
|
|
C4H6N4O |
详情 |
详情
|
(VIII) |
14812 |
methyl 4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoate
|
|
C16H16N4O3 |
详情 |
详情
|
(IX) |
14805 |
4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid
|
|
C15H14N4O3 |
详情 |
详情
|
(X) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(XI) |
14807 |
diethyl (2S)-2-([4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino)pentanedioate
|
|
C24H29N5O6 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(I) The condensation of L-glutamic acid diethyl ester (I) with 4-nitrophthalic anhydride (II) by means of DIEA in refluxing toluene gives the 4-nitrophthalimide (III), which is reduced with H2 over Pd/C to yield the 4-aminophthalimide (IV). The reduction of (IV) with Zn/HCl in ethanol affords a 3:1 mixture of the 5-aminoisoindolinone (V) and 6-aminoisoindolinone (VI) that is separated by chromatography. The desired isomer (V) is condensed with 9-(bromomethyl)-3-methylbenzo[f]quinazolin-1(2H)-one (VII) (obtained by bromination of 3,9-dimethylbenzo[f]quinazolin-1(2H)-one (VIII) with NBS) in DMF at 110?C to provide the precursor (IX). Finally, the ester groups of (IX) are hydrolyzed with NaOH in methanol.
【1】
Pendergast, W.; Dickerson, S.H.; Johnson, J.V.; Ferone, R. (GlaxoSmithKline plc); Pharmaceutically active benzoquinazoline cpds.. EP 0535034; EP 1199307; JP 1993507704; US 5405851; US 5663337; US 6306865; WO 9119700 .
|
【2】
Pendergast, W.; et al.; Benzo[f]quinazoline inhibitors of thymidylate synthase: Methyleneamino-linked aroylglutamate derivatives. J Med Chem 1994, 37, 6, 838.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(II) |
31028 |
5-nitro-2-benzofuran-1,3-dione
|
5466-84-2 |
C8H3NO5 |
详情 | 详情
|
(III) |
56649 |
diethyl (2S)-2-(5-nitro-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)pentanedioate
|
|
C17H18N2O8 |
详情 |
详情
|
(IV) |
56650 |
diethyl (2S)-2-(5-amino-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)pentanedioate
|
|
C17H20N2O6 |
详情 |
详情
|
(V) |
56651 |
diethyl (2S)-2-(5-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)pentanedioate
|
|
C17H22N2O5 |
详情 |
详情
|
(VI) |
56652 |
diethyl (2S)-2-(6-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)pentanedioate
|
|
C17H22N2O5 |
详情 |
详情
|
(VII) |
56653 |
9-(bromomethyl)-3-methylbenzo[f]quinazolin-1(2H)-one
|
|
C14H11BrN2O |
详情 |
详情
|
(VIII) |
56654 |
3,9-dimethylbenzo[f]quinazolin-1(2H)-one
|
|
C14H12N2O |
详情 |
详情
|
(IX) |
56655 |
diethyl (2S)-2-(5-{[(3-methyl-1-oxo-1,2-dihydrobenzo[f]quinazolin-9-yl)methyl]amino}-1-oxo-1,3-dihydro-2H-isoindol-2-yl)pentanedioate
|
|
C31H32N4O6 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(I) Acylation of diethyl L-glutamate (I) with 5-bromo-4-methylthiophene-2-carboxylic acid (II) using EDC as the coupling reagent provided amide (III). Subsequent palladium-catalyzed coupling between bromothiophene (III) and ethynyl pyridopyrimidinone (IV) furnished the disubstituted acetylene (V), which was further hydrogenated to (VI) in the presence of Pd/C in trifluoroacetic acid. Finally, basic hydrolysis of the ethyl ester and pivaloyl groups of (VI) led to the title compound.
【1】
Varney, M.D.; Romines, W.H. (Agouron Pharmaceuticals, Inc.); Cpds. useful as antiproliferative agents and GARFT inhibitors. WO 9603406 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(II) |
55966 |
5-bromo-4-methyl-2-thiophenecarboxylic acid
|
|
C6H5BrO2S |
详情 |
详情
|
(III) |
55967 |
diethyl (2S)-2-{[(5-bromo-4-methyl-2-thienyl)carbonyl]amino}pentanedioate
|
|
C15H20BrNO5S |
详情 |
详情
|
(IV) |
14282 |
N-(6-Ethynyl-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)-2,2-dimethylpropanamide
|
|
C14H14N4O2 |
详情 |
详情
|
(V) |
55968 |
diethyl (2S)-2-({[5-(2-{2-[(2,2-dimethylpropanoyl)amino]-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-6-yl}ethynyl)-4-methyl-2-thienyl]carbonyl}amino)pentanedioate
|
|
C29H33N5O7S |
详情 |
详情
|
(VI) |
55969 |
diethyl (2S)-2-({[5-(2-{2-[(2,2-dimethylpropanoyl)amino]-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl}ethyl)-4-methyl-2-thienyl]carbonyl}amino)pentanedioate
|
|
C29H41N5O7S |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(XX) After removal of the Boc protecting group of (XIV), the resultant free amine spontaneously cyclized to the lactam (XV) in methanolic solution. Lactam (XV) was O-alkylated with trimethyloxonium fluoroborate, yielding the lactim ether (XVI), which was condensed with guanidine (XVII) to produce the pyridothiazine (XVIII). Hydrolysis of the ethyl ester of (XVIII), followed by coupling of the resultant acid (XIX) with L-glutamic acid diethyl ester (XX), furnished amide (XXI). The ester groups of (XXI) were finally hydrolyzed with NaOH to give the title compound.
【1】
Varney, M.D.; et al.; Protein structure-based design, synthesis, and biological evaluation of 5-thia-2, 6-diamino-4(3H)-oxopyrimidines: Potent inhibitors of glycinamide ribonucleotide transformylase with potent cell growth inhibition. J Med Chem 1997, 40, 16, 2502. |
【2】
Varney, M.D.; Palmer, C.L.; Romines, W.H. (Agouron Pharmaceuticals, Inc.); Syntheses of optically pure cpds. useful as GARFT inhibitors and their intermediates. WO 9640674 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIV) |
59504 |
dimethyl 2-({(1S)-1-{[(tert-butoxycarbonyl)amino]methyl}-3-[5-(ethoxycarbonyl)-2-thienyl]propyl}sulfanyl)malonate
|
|
C21H31NO8S2 |
详情 |
详情
|
(XV) |
59505 |
methyl (6S)-6-{2-[5-(ethoxycarbonyl)-2-thienyl]ethyl}-3-oxo-2-thiomorpholinecarboxylate
|
|
C15H19NO5S2 |
详情 |
详情
|
(XVI) |
59506 |
methyl (6S)-6-{2-[5-(ethoxycarbonyl)-2-thienyl]ethyl}-3-methoxy-5,6-dihydro-2H-1,4-thiazine-2-carboxylate
|
|
C16H21NO5S2 |
详情 |
详情
|
(XVII) |
14790 |
Guanidine
|
113-00-8 |
CH5N3 |
详情 | 详情
|
(XVIII) |
59507 |
ethyl 5-{2-[(6S)-2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b][1,4]thiazin-6-yl]ethyl}-2-thiophenecarboxylate
|
|
C15H18N4O3S2 |
详情 |
详情
|
(XIX) |
59508 |
5-{2-[(6S)-2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b][1,4]thiazin-6-yl]ethyl}-2-thiophenecarboxylic acid
|
|
C13H14N4O3S2 |
详情 |
详情
|
(XX) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(XXI) |
59509 |
diethyl (2S)-2-{[(5-{2-[(6S)-2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimido[5,4-b][1,4]thiazin-6-yl]ethyl}-2-thienyl)carbonyl]amino}pentanedioate
|
|
C22H29N5O6S2 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(II) Treatment of hexachlorocyclotriphosphazene (I) with L-glutamic acid diethyl ester (II) in toluene in the presence of Et3N provides the ethyl glutamate derivative of cyclotriphosphazene (III), which is then subjected to saponification with LiOH in H2O to furnish compound (IV) (alternatively, the same procedure can be followed by performing the reaction between (I) and L-glutamic acid dimethyl ester (V) to afford the methyl glutamate derivative of cyclotriphosphazene (VI), which is saponified under the same conditions as (III)). Finally, the target product is obtained by reaction of intermediate (IV) with platinum derivative (VII) by means of Ag2SO4 in water, followed by treatment with BaCl2.H2O and precipitation in acetone.
【1】
Cho, Y.; Sohn, Y.S.; Baek, H.; Lee, C.O.; Synthesis and antitumor activity of cyclotriphosphazene - (diamine)platinum (II) conjugates. Anti-Cancer Drugs 2000, 11, 9, 715.
|
【2】
Lee, C.O.; Sohn, Y.S.; Baek, H.G. (Il-Yang Pharmaceutical Co., Ltd.; Korea Institute of Science and Technology); Platinum complex conjugated to cyclotriphosphazene, its preparation, and anticancer agent comprising the same. EP 1082331; US 6221906; WO 0058321 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
50037 |
Phosphonitrilic Chloride; 1,3,5-Triaza-2,4,6-triphosphorin-2,2,4,4,6,6-hexachloride; Hexachlorotriphosphazene; Phosphonitrilic chloride trimer; 1,3,5,2,4,6-Triazatriphosphorine-2,2,4,4,6,6-hexachloride; Hexachlorocyclotriphosphazene
|
940-71-6 |
Cl6N3P3 |
详情 | 详情
|
(II) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(III) |
50038 |
diethyl (2S)-2-[(2,4,4,6,6-pentakis[[(1S)-4-ethoxy-1-(ethoxycarbonyl)-4-oxobutyl]amino]-1,3,5,2lambda(5),4lambda(5),6lambda(5)-triazatriphosphinin-2-yl)amino]pentanedioate
|
|
C54H96N9O24P3 |
详情 |
详情
|
(IV) |
50039 |
dodecalithium (2S)-2-[(2,4,4,6,6-pentakis[[(1S)-1-carboxylato-4-oxido-4-oxobutyl]amino]-1,3,5,2lambda(5),4lambda(5),6lambda(5)-triazatriphosphinin-2-yl)amino]pentanedioate
|
|
C30H36Li12N9O24P3 |
详情 |
详情
|
(V) |
50040 |
dimethyl (2S)-2-aminopentanedioate
|
|
C7H13NO4 |
详情 |
详情
|
(VI) |
50041 |
dimethyl (2S)-2-[(2,4,4,6,6-pentakis[[(1S)-4-methoxy-1-(methoxycarbonyl)-4-oxobutyl]amino]-1,3,5,2lambda(5),4lambda(5),6lambda(5)-triazatriphosphinin-2-yl)amino]pentanedioate
|
|
C42H72N9O24P3 |
详情 |
详情
|
(VII) |
50042 |
|
|
C6H14I2N2Pt |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(XII) Condensation of the mixed anhydride (XI) with diethyl L-glutamate (XII) produces amide (XIII). The ethyl ester groups of (XIII) are finally hydrolyzed by means of NaOH to provide the title compound.
【1】
Mcguire, J.J.; Zeng, Y.; Gangjee, A.; Kisliuk, R.L.; Synthesis of N-[4-[ethyl-2-(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid as an antifolate. J Med Chem 2002, 45, 9, 1942.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
58987 |
|
|
C22H26N4O5 |
详情 |
详情
|
(XII) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(XIII) |
58989 |
diethyl (2S)-2-[(4-{1-[(2,4-diaminofuro[2,3-d]pyrimidin-5-yl)methyl]propyl}benzoyl)amino]pentanedioate
|
|
C26H33N5O6 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(V)
【1】
Cen JD,Lu AF. 2006.Method for preparation of folic acid antagonist and its intermediate. 发明专利申请公开说明书, CN 1880316 |
【2】
Fan CW. Lin D. Shan YQ, et aL 2006. Preparation of pemetrexed from L-glutamic acid and 4-[2- (2-α-mino-4,7-dihydro-4-oxo-3h-pyrrolo-[2,3-d] pyrimidirr-5-yl) ethyl] benzoic acid. 发明专利申请公开说明书.CN 1840530 |
【3】
Lin D, Fan CW, Zhu YD, et al. 2006. Process for preparation of nitro compounds as intermediates for synthesizing pemetrexed. 发明专利申请公开说明书, CN 1827604 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
66570 |
methyl 4-(2-oxoethyl)benzoate |
|
C10H10O3 |
详情 | 详情
|
(II) |
66571 |
methyl 4-(2-hydroxy-3-nitropropyl)benzoate |
|
C11H13NO5 |
详情 | 详情
|
(III) |
66572 |
4-(2-hydroxy-3-nitropropyl)benzoic acid |
|
C10H11NO5 |
详情 | 详情
|
(IV) |
66573 |
4,6-dimethoxy-1,3,5-triazin-2-yl 4-(2-hydroxy-3-nitropropyl)benzoate |
|
C15H16N4O7 |
详情 | 详情
|
(V) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(VI) |
66574 |
(2R)-diethyl 2-(4-(2-hydroxy-3-nitropropyl)benzamido)pentanedioate |
|
C19H26N2O8 |
详情 | 详情
|
(VII) |
66575 |
(R,E)-diethyl 2-(4-(3-nitroallyl)benzamido)pentanedioate |
|
C19H24N2O7 |
详情 | 详情
|
(VIII) |
66576 |
(2R)-diethyl 2-(4-(2-(4,6-diamino-2-oxo-1,2-dihydropyridin-3-yl)-3-nitropropyl)benzamido)pentanedioate |
|
C24H31N5O8 |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(V)
【1】
Taylor EC, Liu B 2000. Process for the preparation of pyrrolo [2,3-d] pyrirnidines. W0 2000011004 |
【2】
Taylor EC, Liu R. 2002. A new and efficient synthesis of pyrrolo [2,3-d] pyrimidines. anticancer agents: alimta (LY231514, MTA), homo-alimta, TNP-351, and some aryl 5-substituted pyrrolo [2,3-d] pyrimidines. J Org Chem, 68: 9938~9947 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14800 |
ethyl 4-(3-oxopropyl)benzoate
|
|
C12H14O3 |
详情 |
详情
|
(II) |
66577 |
(E)-ethyl 4-(4-nitrobut-3-en-1-yl)benzoate |
|
C13H15NO4 |
详情 | 详情
|
(III) |
66578 |
ethyl 4-(3-(2,4-diamino-6-hydroxypyrimidin-5-yl)-4-nitrobutyl)benzoate |
|
C17H21N5O5 |
详情 | 详情
|
(IV) |
66579 |
4-(2-(2-amino-4-hydroxy-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoic acid |
|
C15H14N4O3 |
详情 | 详情
|
(V) |
11013 |
diethyl (2S)-2-aminopentanedioate
|
|
C9H17NO4 |
详情 |
详情
|
(VI) |
14807 |
diethyl (2S)-2-([4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino)pentanedioate
|
|
C24H29N5O6 |
详情 |
详情
|